Literature DB >> 16117783

The risk of cancer among patients previously hospitalized for atopic dermatitis.

Anne Braae Olesen1, Gerda Engholm, Hans Henrik Storm, Kristian Thestrup-Pedersen.   

Abstract

In treatment of severe atopic dermatitis, drugs with carcinogenic potentials are used to manage the disease. We therefore analyzed whether patients having severe atopic eczema had an increased cancer risk. The study population included all individuals hospitalized in Denmark with a primary diagnosis of atopic dermatitis during 1977-1996. Follow-up was conducted in 1996 in the Danish Cancer Register. A total of 6275 persons were included. Among 2030 adult patients, an increased risk of cancer was observed, standard morbidity ratio (SMR)=1.5 (95% CI: 1.2-1.9). Half the excess cases of cancer was keratinocyte carcinomas of the skin diagnosed within the first 9 y of follow-up, SMR=2.4 (95% CI: 1.4-3.9). For men, SMR=2.7 (95%CI: 1.2-5.4). In conclusion, earlier hospitalized adult atopic dermatitis patients had an increased risk of cancer. Half the excess cases of cancer were keratinocyte carcinomas. This may be a result of a detection bias or due to the carcinogenic potentials of some of the therapies of severe atopic dermatitis.

Entities:  

Mesh:

Year:  2005        PMID: 16117783     DOI: 10.1111/j.0022-202X.2005.23839.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

1.  The potential for malignancy from atopic disorders and allergic inflammation: A systematic review and meta-analysis.

Authors:  Amanda B Muir; Kelly A Whelan; Michael K Dougherty; Bailey Aaron; Brianna Navarre; Seema S Aceves; Evan S Dellon; Elizabeth T Jensen
Journal:  Clin Exp Allergy       Date:  2019-12-20       Impact factor: 5.018

2.  History of allergy and atopic dermatitis in relation to squamous cell and Basal cell carcinoma of the skin.

Authors:  Judy Cheng; M Scot Zens; Eric Duell; Ann E Perry; M Shane Chapman; Margaret R Karagas
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-02-10       Impact factor: 4.254

3.  Noncutaneous and Cutaneous Cancer Risk in Patients With Atopic Dermatitis: A Systematic Review and Meta-analysis.

Authors:  Lily Wang; Rachel Bierbrier; Aaron M Drucker; An-Wen Chan
Journal:  JAMA Dermatol       Date:  2020-02-01       Impact factor: 10.282

4.  Atopic Dermatitis and Skin Cancer Risk: A Systematic Review.

Authors:  Yun Zhu; Hongmei Wang; Juan He; Luhui Yang; Xiaoyan Zhou; Zhe Li; Huiling Zhou; Huadi Zhao; Yuye Li
Journal:  Dermatol Ther (Heidelb)       Date:  2022-04-17

5.  Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study.

Authors:  Sarah N Robinson; Michael S Zens; Ann E Perry; Steven K Spencer; Eric J Duell; Margaret R Karagas
Journal:  J Invest Dermatol       Date:  2013-01-23       Impact factor: 8.551

6.  Clinical Characteristics, Treatments, and Prognosis of Atopic Eczema in the Elderly.

Authors:  Ryoji Tanei
Journal:  J Clin Med       Date:  2015-05-18       Impact factor: 4.241

7.  Association between cancer and allergies.

Authors:  Renata Kozłowska; Andrzej Bożek; Jerzy Jarząb
Journal:  Allergy Asthma Clin Immunol       Date:  2016-08-11       Impact factor: 3.406

Review 8.  Comorbidities of Atopic Dermatitis: Beyond Rhinitis and Asthma.

Authors:  Yuki M F Andersen; Alexander Egeberg; Lone Skov; Jacob P Thyssen
Journal:  Curr Dermatol Rep       Date:  2017-01-21

Review 9.  Allergy-Related Diseases and Risk of Breast Cancer: The Role of Skewed Immune System on This Association.

Authors:  Fatemeh Sadeghi; Mohammad Shirkhoda
Journal:  Allergy Rhinol (Providence)       Date:  2019-07-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.